SyVento says bringing the FlexFactory to Poland makes new therapies available to patients in an efficient and high-quality way.

BioNTech plans to further investigate the drug’s potential in combination with mRNA vaccines, targeted therapies and ...

Expects to complete enrollment of the 400-participant sentinel cohort for the COVID-19 Phase 2b study in November 2024 Solid financial position enables Vaxart to attain multiple regulatory and ...

Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines.

Most people don’t enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good afternoon and welcome everyone to the GeoVax Third Quarter 2024 Corporate Update Call. My name is Michelle and I will facilitate today ...

A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such ...

The study demonstrates that activating the vitamin D receptor (VDR) with calcitriol suppresses cell proliferation in ...

Not long after netting $57m in financing, Inflammatix has kick started a clinical trial evaluating its technology for the ...

Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...